Sponsor or institution

Clinical trials and research at Shanghai Cell Therapy Group Co.,Ltd

• 8Clinical trials
• 1Country

Newest trials

All recruiting trials (8)

• Antibody-armored dendritic cell therapy for people with solid tumors

  This will test a single injection of antibody-armored dendritic cells in adults with certain resected solid tumors after standard adjuvant chemotherapy to see if it is safe and stimulates an immune response.

  Recruiting Phase 1 Shanghai Cell Therapy Group Co.,Ltd · Shanghai · NCT07479667

• CD19/CD22/BCMA CAR‑T (BZE2204) for relapsed or refractory autoimmune diseases

  This will test whether a personalized CAR‑T cell therapy (BZE2204) targeting CD19, CD22, and BCMA can help adults with relapsed or refractory IIM, ITP, or SLE.

  Recruiting Early Phase 1 Shanghai Cell Therapy Group Co.,Ltd · Shanghai, Shanghai Municipality · NCT07174843

• Super DC cell injections to prevent tumor recurrence after surgery.

  This trial will test whether injections of a Super DC vaccine can help prevent solid tumors from coming back in adults who have had their tumors completely removed.

  Recruiting Phase 1/2 Shanghai Cell Therapy Group Co.,Ltd · Shanghai · NCT07146672

• Testing a new CAR-T therapy for multiple myeloma

  This study is testing a new CAR-T therapy for people with hard-to-treat multiple myeloma to see how safe it is and what the best dose is.

  Recruiting Early Phase 1 Shanghai Cell Therapy Group Co.,Ltd · Shanghai · NCT06732232

• Dose-escalation of CD19/CD22/BCMA CAR‑T for relapsed or refractory B‑cell non‑Hodgkin lymphoma

  This trial will try a CAR‑T therapy that targets CD19, CD22, and BCMA in people with relapsed or refractory B‑cell non‑Hodgkin lymphoma to find a safe dose.

  Recruiting Early Phase 1 Shanghai Cell Therapy Group Co.,Ltd · Shanghai, Shanghai Municipality · NCT06446128

• Exploring Fast CAR T Cell Therapy for Advanced Solid Tumors

  This study is testing a new type of CAR T cell therapy to see if it can help people with advanced solid tumors that have certain markers.

  Recruiting Early Phase 1 Shanghai Cell Therapy Group Co.,Ltd · Shanghai, Shanghai Municipality · NCT06327997

• Treatment of advanced solid tumors using fast CAR T cells

  This study is testing a new type of CAR T cell therapy to see if it can help people with advanced solid tumors who haven't had success with other treatments.

  Recruiting Early Phase 1 Shanghai Cell Therapy Group Co.,Ltd · Shanghai, Shanghai Municipality · NCT06249256

• Using engineered T cells to treat advanced solid tumors

  This study is testing a new treatment using specially engineered T cells to see if it can help people with advanced solid tumors that haven't responded to other therapies.

  Recruiting Early Phase 1 Shanghai Cell Therapy Group Co.,Ltd · Shanghai, Shanghai Municipality · NCT06248697

Quick answers

How many clinical trials run by Shanghai Cell Therapy Group Co.,Ltd are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Early Phase 1: 6, Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →